MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
"Triple Helix" Innovation Model
4. Triple Helix _ Capture Strategies
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Switzerland
Biocartis SA
Attachments
Biocartis
Parents
*Architects: Diagnostics_In Vitro Diagnostics (IVD)
*Architects: Molecular Diagnostics
*Industry: Switzerland
Extraordinary Corporate Investments, and/or Multiple Strategics
Children
A launch is anticipated for 2013.
Biocartis seeks to create new diagnostics with applications in infectious diseases and personalized medicine.
Its first product, Apollo , is a fully automated, compact MDx system based on technology licensed from Royal Philips Electronics NV .
Participating were Debiopharm Group , Philips , Johnson & Johnson Development Corp., Biovest, Benaruca, Wellcome Trust, Korys, Valiance, IHL SA (Luc Verelst), PMV, and New Rhein Healthcare.
Series C $100M by OnBioVC (2012)
Series C generates €71mm for Biocartis (2011)
This Series C is the largest private financing for a diagnostics company since July 2010 when Pacific Biosciences brought in $109mm via its Series F round. (2011)
Jumps
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
Koninklijke Philips N.V. (NYSE:PHG)
Wellcome Trust